I år forventer agenturet desuden at modtage de første ansøgninger om godkendelse af generiske lægemidler.
Owing to the new legislation, the Agency expects to receive the first authorisation applications for generic medicines this year, and will assume full responsibility for evaluating medicines intended for the treatment of HIV/ AIDS, cancer, diabetes and neurodegenerative disorders, which must now be authorised through the centralised procedure.